16 Grants
2021
A Fragment-Based Strategy for K-RAS Covalent Inhibitors
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA264471-01), $469,217USD, 2021-07-02 -- 2025-06-30
 
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
Androphy, Elliot J and Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA252715-01A1), $632,904USD, 2021-05-01 -- 2026-04-30
 
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury
Meroueh, Samy
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01BX005188-01), 2020-10-01 -- 2024-09-30
2020
Small-Molecule Antagonists of Ral GTPases in Cancer
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA197928-05), $586,717USD, 2016-04-01 -- 2021-03-31
2019
Small-Molecule Antagonists of Ral GTPases in Cancer
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA197928-04), $569,116USD, 04/01/2016 -- 03/31/2021
2018
Small-Molecule Antagonists of Ral GTPases in Cancer
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA197928-03), $528,045USD, 04/01/2016 -- 03/31/2021
2017
Small-Molecule Antagonists of Ral GTPases in Cancer
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA197928-02), $531,822USD, 04/01/2016 -- 03/31/2021
2016
Small-Molecule Antagonists of Ral GTPases in Cancer
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA197928-01A1), $602,597USD, 04/01/2016 -- 03/31/2021
2012
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA135380-04), $247,971USD, 05/15/2009 -- 02/28/2014
2011
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA135380-03), $247,971USD, 05/15/2009 -- 02/28/2013
 
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence
HURLEY, THOMAS D and Meroueh, Samy
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R21AA019746-02), $185,031USD, 07/01/2010 -- 06/30/2013
2010
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA135380-02), $255,640USD, 05/15/2009 -- 02/28/2013
 
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence
HURLEY, THOMAS D and Meroueh, Samy
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 1R21AA019746-01), $231,000USD, 07/01/2010 -- 06/30/2012
2009
A WEB INTERFACE FOR SCORING IN COMPUTATIONAL DRUG DESIGN
Meroueh, Samy
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5P41RR006009-19), $771USD, 08/01/2009 -- 07/31/2010
 
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe
Meroueh, Samy
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA135380-01A1), $255,640USD, 05/15/2009 -- 02/28/2013
2008
A WEB INTERFACE FOR SCORING IN COMPUTATIONAL DRUG DESIGN
Meroueh, Samy
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5P41RR006009-18-5632), $473USD, 08/01/2008 -- 07/31/2009